| Active ingredient (INN) | Cabergoline |
|---|---|
| Brand names | Cabaser, Cabergolina Teva, CABASER Cabergoline |
| ATC level 5 | G02CB03 |
| ATC level 4 | G02CB |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Pfizer Australia Pty Ltd, TEVA UK LIMITED, MILPHARM LIMITED, RENATA (UK) LIMITED +3 more |
| Registrations on file | 16 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| DOSTINEX cabergoline | 0.5mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| CABERGOLINE 0.5MG TABLETS | 0.5MG | tablet | 🇬🇧 GB | TEVA UK LIMITED | Active |
| CABERGOLINE 1 MG TABLETS | 1 MG | tablet | 🇬🇧 GB | TEVA UK LIMITED | Active |
| CABERGOLINE 2MG TABLETS | 2MG | tablet | 🇬🇧 GB | TEVA UK LIMITED | Active |
| Apotex | 500 microgram | tab | 🇦🇺 AU | — | Active |
| GenRx | 500 microgram | tab | 🇦🇺 AU | — | Active |
| CABERGOLINE 0.5 MG TABLETS | 0.5 MG | tablet | 🇬🇧 GB | MILPHARM LIMITED | Active |
| CABERGOLINE 2 MG TABLETS | 2 MG | tablet | 🇬🇧 GB | RENATA (UK) LIMITED | Active |
| Cabergoline | .5mg/1 | tablet | 🇺🇸 US | TEVA PHARMACEUTICALS USA, INC. | Active |
| CABASER Cabergoline | 1mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| CABASER Cabergoline | 2mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| TINEXA cabergoline | 0.5mg | tabuc | 🇦🇺 AU | — | Active |
| BERGOLINE cabergoline | 1mg | tabuc | 🇦🇺 AU | — | Active |
| BERGOLINE cabergoline | 2mg | tabuc | 🇦🇺 AU | — | Active |
| Apo-Cabergoline | — | tablet | 🇨🇦 CA | APOTEX INC | Active |